Close Menu

A Gold Star

In The Scientist, Jeff Akst writes that NIH reviewers who have participated in funding rounds since the shorter applications and new guidelines were put into place are generally happy with the changes. "I think it's an improvement over the old system, but I think there is a learning curve and until everyone recalibrates there may be a period of confusion," says Karin Rodland at the Pacific Northwest National Laboratory.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.